South Wales, July 11 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "SANDPIPER THERAPEUTICS" on July 3. The details about the trademark application no. UK00004228867 published in the journal no. 2025/028 (July 11).
With CMS Cameron McKenna Nabarro Olswang LLP as representative, Sandpiper Therapeutics, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical and medical preparations; pharmaceutical preparations for use in oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; biological preparations for use in oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; therapeutic pharmaceuticals for use in oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; biological therapies for use in oncology, immunology, cardiometabolic diseases, and cardiovascular diseases.
Class 42 : Product research, design and development services; pharmaceutical research, design and development services; scientific and medical research; research and development in the field of therapeutics; drug discovery services; project management in the field of pharmaceutical development; research and development in the field of small molecule drug discovery for use in oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; pharmaceutical products development in the fields of oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; scientific research for medical purposes in the fields of oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; pharmaceutical research and development services in the fields of oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; research and development of therapeutics for use in oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; drug discovery services in the fields of oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; research and development in the field of precision medicine for use in oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; medical and scientific research in the fields of oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; information, consultancy and advisory services in relation to all of the above.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004228867
Disclaimer: Curated by HT Syndication.
